← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2004Last known activity
Oct 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT06270407CollaboratorPhase 4Oct 31, 2024
- NCT05343611CollaboratorN/AMay 1, 2022
- NCT04574713CollaboratorPhase 2Nov 9, 2020
- NCT02890290Lead sponsorN/ASep 1, 2016
- NCT00360906Overall official - principal investigatorPhase 2/Phase 3Dec 1, 2004
Details
- Last known activity
- Oct 31, 2024